Article

National Comprehensive Cancer Network Guideline Updates From the 15th Annual Congress

Credits: 1.0 contact hours (0.10 CEUs)

Anthony Elias, MD, Professor of Medicine, Medical Director, Breast Cancer and Sarcoma Programs, University of Colorado Cancer Center

Educational Objectives

After completing this activity, participants should be able to:

  • List some of the major National Comprehensive Cancer Network (NCCN) practice guideline revisions presented at the 15th Annual Congress
  • Identify select NCCN guideline revisions that may impact the course of treatment in a given case
  • Discuss the use of patient characteristics to determine therapeutic management in select NCCN guideline revisions

Target Audience: Pharmacy directors/administrators, clinical pharmacists practicing in managed care environments, and any other pharmacist practitioners involved in the care of patients diagnosed with cancer.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Martin Engelke
David Awad, PharmD, BCOP
Dr Adela Perolla
Dr Adela Perolla | Image Credit: - stock.adobe.com
4 experts are featured in this series.
4 experts are featured in this series.
2 experts in this video
4 experts are featured in this series.
2 experts in this video
Dr Ola Landgren
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo